Published in Medical Letter on the CDC and FDA, November 27th, 2005
Alza Corp. is committed to developing safe and effective medicines that address important unmet medical needs. The company continues to believe that dapoxetine provides important benefits for men who suffer from PE. Alza plans to address questions raised in the FDA letter and continue the global development program.
PE is a distinct medical condition that has been recognized by the American Urological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.